Conjunctivitis Does Not Increase With Longer Duration of Lebrikizumab Exposure in Patients With Moderate-to-Severe Atopic Dermatitis. J of Skin 2023, 7 (6), s276. https://doi.org/10.25251/skin.7.supp.276.